Skip to content

De NiceDay Smartphone App: "De pacemaker van de psychiatrie"

Behavioral activation using a smartphone application in patients with a major depressive disorder (BE POSITIVE)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23664
Enrollment
150
Registered
2019-02-04
Start date
2021-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

None listed

Sponsors

PsyQ Parnassia Groep
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants are eligible if they are/have: - 18 years or older - unipolar moderate to severe depressive disorder (criteria DSM-5); - possessing a smartphone.

Exclusion criteria

Exclusion criteria: Patients cannot participate if they: - do not speak Dutch; - have incompetent skills to manage smartphone (applications); - have severe psychiatric comorbidities, i.e. psychosis, personality disorders, intoxications / addictions (axis II); - have severe physical comorbidities (axis III); - have severe psychosocial and environmental problems (axis IV) - use drugs or medication which interferes with the use of the smartphone application (i.e. cannabis, strong sedatives / pain killers, alcohol abuse)

Design outcomes

Primary

MeasureTime frame
The most important outcome measure of this study is “Speed of remission ”, which is a measure of the speed with which symptom reduction takes place as a result of the therapy. Since the costs of the applied interventions are known at the level of minutes, it is possible to calculate the costs of remote digital therapy.

Secondary

MeasureTime frame
Apart from psychometrics, we measure Quality Of Life and (to a limited extent) physical health parameters.

Contacts

Public ContactRutger Goekoop

PsyQ

r.goekoop@parnassiagroep.nl088 - 3573107

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)